New Products

MEAD, Wash. — Movit Energy Gummies recently launched its signature product targeting active sports enthusiasts with an energy product in gummy format. 

Movit comes in a snack-size packet typically containing 11 gummies, which altogether contain 60 calories, in one of two flavors — citrus or berry. The proprietary formula includes such ingredients as Brazilian guarana, co-enzyme Q10, D-ribose, vitamin C, taurine, protein and a full complement of B vitamins.

The energy formula meets high school and NCAA guidelines, the company stated.

PRINCETON, N.J. — Sandoz has launched an authorized generic version of a topical drug for treating actinic keratosis, the company said.

Sandoz, the generics arm of Swiss drug maker Novartis, announced the launch of authorized generic diclofenac gel in the 3% strength. The drug is a version of PharmaDerm's Solaraze.

JERUSALEM — Teva Pharmaceutical Industries has launched its generic version of a drug for patients with cystic fibrosis, the Israeli drug maker said Thursday.

Teva announced the launch of tobramycin inhalation solution, a generic version of Novartis' drug Tobi. The Food and Drug Administration approved Teva's product last month. The drug is used to treat CF in patients whose lungs contain bacteria called Pseudomonas aeroginosa.

Tobi had sales of about $350 million during the 12-month period that ended in June, according to IMS Health.

NEW YORK — The Food and Drug Administration has granted regular approval to a new drug made by Pfizer for treating a form of lung cancer, the drug maker said.

FLINT, Mich. — Cornerstone Therapeutics has added specialty pharmacy Diplomat to its limited-distribution network for a newly approved treatment for cystic fibrosis, Diplomat said Friday.

Diplomat will distribute Bethkis (tobramycin inhalation solution), which received Food and Drug Administration approval in October for treating chronic bacterial lung infections caused by P. aeruginosa in cystic fibrosis patients.

NORTH WALES, Pa. – Teva has introduced a generic version of a drug used to treat attention deficit hyperactivity disorder, the company said Thursday.

The drug maker announced the launch of dexmethylphenidate hydrochloride extended-release capsules, a generic version of Novartis' Focalin XR.

Focalin XR has annual sales of about $202 million, according to IMS Health.

BETHESDA, Md. — Honest Tea, maker of organic bottled tea, is rolling out Unsweet Lemon Tea nationwide, the company announced. The zero-calorie beverage is brewed with organic, Fair Trade-certified tea leaves and flavored with organic lemon extract.  

MADISON, Tenn. — Vireo Systems on Thursday launched CanineActiv, a pain reliever for dogs that will serve as an alternative to NSAIDs. "We have had outstanding success with NSAID alternatives for people, and we knew that many of our discoveries and innovations could be extended to dogs," Mark Faulkner, Vireo Systems president said. "With CanineActiv, consumers can expect the same level of safe and effective pain relief for their dogs as they've come to expect for themselves from AminoActiv."